Real-World Anticoagulatory Treatment After Transcatheter Aortic Valve Replacement: A Retrospective, Observational Study on 4,800 Patients

Background: Transcatheter aortic valve replacement (TAVR) has developed to the therapy of choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical aortic valve replacement and elderly patients with intermediate or high operative risk. However, the optimal anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohmann, Christopher, Ludwig, Marion, Walker, Jochen, Wienemann, Hendrik, Baldus, Stephan, Pfister, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733398/
https://www.ncbi.nlm.nih.gov/pubmed/35004894
http://dx.doi.org/10.3389/fcvm.2021.780762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733398/
https://www.ncbi.nlm.nih.gov/pubmed/35004894
http://dx.doi.org/10.3389/fcvm.2021.780762

Ejemplares similares